Hamilton A J, Cymmerman A, Black P M
Neurosurgery. 1986 Nov;19(5):841-9. doi: 10.1227/00006123-198611000-00024.
Acute mountain sickness (AMS) is usually a benign and self-limited illness that befalls previously healthy individuals who ascend rapidly to high altitude without sufficient acclimatization. In its more severe forms, AMS can progress to a life-threatening condition in which pulmonary or cerebral edema can occur singly or in concert. High altitude cerebral edema (HACE) is a little-known clinical entity that manifests itself by a perplexing array of both generalized and localized neurological symptoms and signs. Furthermore, the development of HACE in climbers offers a unique experimental situation in which to examine the effects of hypoxia on the central nervous system. The epidemiology and clinical picture of HACE are reviewed. In addition, the pathology and predominant pathophysiological mechanisms postulated to explain HACE are examined, and the present recommendations for the prevention and treatment of this dangerous and unusual form of brain swelling are discussed.
急性高原病(AMS)通常是一种良性的自限性疾病,发生于先前健康但未充分适应环境就迅速攀登到高海拔地区的个体。在其更严重的形式中,AMS可发展为危及生命的状况,其中肺水肿或脑水肿可单独或同时发生。高原脑水肿(HACE)是一种鲜为人知的临床病症,其表现为一系列令人困惑的全身和局部神经症状及体征。此外,登山者发生HACE为研究缺氧对中枢神经系统的影响提供了一个独特的实验环境。本文回顾了HACE的流行病学和临床表现。此外,还研究了为解释HACE而提出的病理及主要病理生理机制,并讨论了目前针对这种危险且罕见的脑肿胀形式的预防和治疗建议。